The economic consequences of Alzheimer's
β
Martin Knapp; David Wilkinson; Rachel Wigglesworth
π
Article
π
1998
π
John Wiley and Sons
π
English
β 165 KB
π 3 views
The first national symptomatic treatment for Alzheimer's disease has received a very mixed and perhaps ageist reception from purchasers of health care in the UK. This is largely because detailed information on the long-term effects of this class of drugs is scarce. However, by looking at the publish